Yamamoto K, Nakajima A, Eimoto H, Takashima Y, Tsujiuchi T, Sugimura M, Konishi Y
Department of Oral and Maxillofacial Surgery, Nara Medical College, Japan.
Exp Pathol. 1990;38(1):53-9. doi: 10.1016/s0232-1513(11)80198-2.
Dose response to the carcinogenic activity of N-nitrosomethyl(2-hydroxypropyl)amine (MHP) was investigated for the nasal cavity of male Wistar rats. MHP dissolved in 0.9% saline was administered intraperitoneally once a week for 12 weeks at doses of 0, 4.4, 8.8 and 17.6 mg/kg body weight, and all surviving animals were sacrificed 26 weeks after the beginning of the experiment. Hyperplasias, papillomas and squamous cell carcinomas were induced. Hyperplasias could be divided into flat, protruding and downgrowth types and were observed in respiratory and squamous epithelial regions. Papillomas and squamous cell carcinomas developed in the respiratory region, and the incidence of the latter reached 83% in rats which received the highest dose of MHP. These results indicate that MHP shows its carcinogenic activity of the nasal cavity by the development of squamous cell carcinomas.
研究了N-亚硝基甲基(2-羟丙基)胺(MHP)对雄性Wistar大鼠鼻腔致癌活性的剂量反应。将溶解于0.9%生理盐水中的MHP以0、4.4、8.8和17.6mg/kg体重的剂量每周腹腔注射一次,持续12周,所有存活动物在实验开始后26周处死。诱导出了增生、乳头状瘤和鳞状细胞癌。增生可分为扁平型、突出型和向下生长型,在呼吸上皮和鳞状上皮区域均有观察到。乳头状瘤和鳞状细胞癌发生在呼吸区域,接受最高剂量MHP的大鼠中鳞状细胞癌的发生率达到83%。这些结果表明,MHP通过鳞状细胞癌的发生显示出其鼻腔致癌活性。